| NOUV Stock | | | USD 0.0001 0.0001 50.00% |
Insider
Brian Shibley is CEO Chairman of Nouveau Life Pharmaceuticals
| Phone | 954-903-2993 |
| Web | http://www.nlpnaturals.com |
Nouveau Life Management Efficiency
The company has return on total asset
(ROA) of
(0.1983) % which means that it has lost $0.1983 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
(2.1952) %, meaning that it created substantial loss on money invested by shareholders. Nouveau Life's management efficiency ratios could be used to measure how well Nouveau Life manages its routine affairs as well as how well it operates its assets and liabilities.
Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in the development of nutraceuticals products. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of EMG Marketing Solutions, Inc. Nouveau Life is traded on OTC Exchange in the United States. Nouveau Life Pharmaceuticals [NOUV] is a
Pink Sheet which is traded between brokers as part of OTC trading.
Management Performance
Nouveau Life Pharmac Leadership Team
Elected by the shareholders, the Nouveau Life's board of directors comprises two types of representatives: Nouveau Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nouveau. The board's role is to monitor Nouveau Life's management team and ensure that shareholders' interests are well served. Nouveau Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nouveau Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
Nouveau Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Nouveau Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Nouveau Pink Sheet Analysis
When running Nouveau Life's price analysis, check to
measure Nouveau Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nouveau Life is operating at the current time. Most of Nouveau Life's value examination focuses on studying past and present price action to
predict the probability of Nouveau Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nouveau Life's price. Additionally, you may evaluate how the addition of Nouveau Life to your portfolios can decrease your overall portfolio volatility.